CASI Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy CASI Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CASI Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CASI Pharmaceuticals Inc. is CASI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CASI Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade CASI Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CASI Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CASI Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CASI Pharmaceuticals Inc..